======= TAF15 ======= == Gene Information == * **Official Symbol**: TAF15 * **Official Name**: TATA-box binding protein associated factor 15 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8148|8148]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q92804|Q92804]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TAF15&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TAF15|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601574|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the TET family of RNA-binding proteins. The encoded protein plays a role in RNA polymerase II gene transcription as a component of a distinct subset of multi-subunit transcription initiation factor TFIID complexes. Translocations involving this gene play a role in acute leukemia and extraskeletal myxoid chondrosarcoma, and mutations in this gene may play a role in amyotrophic lateral sclerosis. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, May 2012]. * **UniProt Summary**: RNA and ssDNA-binding protein that may play specific roles during transcription initiation at distinct promoters. Can enter the preinitiation complex together with the RNA polymerase II (Pol II). {ECO:0000269|PubMed:19124016}. |zf-RanBP| |RRM 1| |transcription initiation from RNA polymerase II promoter| |regulation of signal transduction by p53 class mediator| |DNA-templated transcription, initiation| |transcription by RNA polymerase II| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |nucleolus| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |RNA binding| |DNA binding| |positive regulation of transcription, DNA-templated| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |regulation of intracellular signal transduction| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|-2.11| |[[:results:exp472|CI-1040 9.5μM R08 exp472]]|-1.9| |[[:results:exp20|Etoposide 10μM R00 exp20]]|-1.9| |[[:results:exp461|BS-181 20μM R08 exp461]]|1.73| |[[:results:exp480|ETC-159 50μM R08 exp480]]|1.73| |[[:results:exp417|Tubastatin-A 2.5μM R07 exp417]]|1.79| |[[:results:exp358|FK-506 5μM R07 exp358]]|1.81| |[[:results:exp390|Pifithrin-alpha 20μM R07 exp390]]|1.94| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|1.98| |[[:results:exp274|Citral 50μM R06 exp274]]|2.01| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|2.11| |[[:results:exp330|5-Azacytidine 2μM R07 exp330]]|2.15| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|2.27| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|2.27| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|2.31| |[[:results:exp222|Betulinic acid 10 to 15μM on day4 R05 exp222]]|2.49| |[[:results:exp306|Rapamycin 2μM R07 exp306]]|2.49| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|2.76| |[[:results:exp135|MS023 7μM R03 exp135]]|3.85| |[[:results:exp134|MS023 2μM R03 exp134]]|5.14| ^Gene^Correlation^ |[[:human genes:g:golga6l1|GOLGA6L1]]|0.521| |[[:human genes:c:c14orf93|C14orf93]]|0.46| |[[:human genes:p:psmb4|PSMB4]]|0.441| |[[:human genes:n:npipb5|NPIPB5]]|0.437| |[[:human genes:p:psap|PSAP]]|0.424| |[[:human genes:r:rrn3|RRN3]]|0.42| |[[:human genes:p:paf1|PAF1]]|0.419| |[[:human genes:c:cep192|CEP192]]|0.417| |[[:human genes:s:supt6h|SUPT6H]]|0.417| |[[:human genes:c:cdc73|CDC73]]|0.414| |[[:human genes:s:snrnp70|SNRNP70]]|0.414| |[[:human genes:r:rps9|RPS9]]|0.408| |[[:human genes:r:rps5|RPS5]]|0.404| |[[:human genes:s:supt5h|SUPT5H]]|0.403| |[[:human genes:a:atp6v0c|ATP6V0C]]|0.4| |[[:human genes:r:rpl35|RPL35]]|0.4| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2028 * **Expression level (log2 read counts)**: 8.17 {{:chemogenomics:nalm6 dist.png?nolink |}}